🔎 Trials Near Me

Utama › Kanser Paru-paru Bukan Sel Kecil › Georgia › Savannah

Kajian klinikal Kanser Paru-paru Bukan Sel Kecil di Savannah, GA

10 kajian untuk Kanser Paru-paru Bukan Sel Kecil sedang mencari peserta di lokasi dalam dan sekitar Savannah (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Mengambil pesertaFasa 3
  • Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah
  • Saint Joseph's/Candler - Bluffton Campus, Bluffton · 18 mi jauh
  • South Carolina Cancer Specialists PC, Hilton Head Island · 22 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Okt 2026 · NCT04267848

A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)

Mengambil pesertaFasa 3
  • Low Country Cancer Care ( Site 0156), Savannah
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07190248

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Mengambil pesertaFasa 3
  • Lewis Cancer and Research Pavilion ( Site 0063), Savannah
  • Saint Joseph's Candler Health System ( Site 4010), Bluffton · 18 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06312137

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Mengambil pesertaFasa 3
  • Research Site, Savannah
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Sep 2026 · NCT06692738

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Mengambil pesertaFasa 2
  • Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah
  • Saint Joseph's/Candler - Bluffton Campus, Bluffton · 18 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Jun 2026 · NCT05642572

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Mengambil pesertaFasa 2/3
  • Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah
  • Saint Joseph's/Candler - Bluffton Campus, Bluffton · 18 mi jauh
  • South Carolina Cancer Specialists PC, Hilton Head Island · 22 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Mei 2026 · NCT06616584

JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer

Mengambil pesertaFasa 3
  • Curtis and Elizabeth Anderson Cancer, Savannah
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Apr 2026 · NCT02468024

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Mengambil pesertaKajian pemerhatian
  • Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah
  • Saint Joseph's/Candler - Bluffton Campus, Bluffton · 18 mi jauh
  • The Radiation Oncology Center-Hilton Head/Bluffton, Hilton Head Island · 22 mi jauh
  • dan 1 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Mac 2026 · NCT06418204

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Mengambil pesertaKajian pemerhatian
  • Massive Bio SYNERGY-AI site, Savannah
Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774

Kajian Kanser Paru-paru Bukan Sel Kecil di bandar lain

Kajian lain di Savannah

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.